TABLE 2.
Classifications of Component Defects
| Type of component defect | Description of defect(s) | % of PIDDs | Common associated disorder(s) |
|---|---|---|---|
| B cell defects | Antibody production deficiencies Decreased antibody titers B cell dysfunction |
50–60% | Selective IgA deficiency XLA CVID IgG subclass deficiency Specific antibody deficiency Autosomal recessive agammaglobulinemia Selective IgM deficiency Good’s syndrome |
| T cell defects | Immunoglobulin deficiencies | 5–10% | DiGeorge syndrome ZAP-70 deficiency X-linked lymphoproliferative syndrome Chronic mucocutaneous candidiasis |
| Combined B and T cell defects | Impaired antibody formation | 20% | Severe combined immunodeficiency Ataxia Telangiectasia Wiskott-Aldrich syndrome |
| Natural killer defects | Probable predisposition to viral infection and tumors (very rare) | NA | NA |
| Phagocytic cell defects | Impaired pathogen destruction | 10–15% | Chronic granulomatous disease Leukocyte adhesion deficiency syndrome Chédiak-Higashi syndrome |
| Complement defects | Deficiencies of complement components or inhibitors | ≤2% | Systemic lupus erythematosus Pyogenic infections Autoimmune disorders Angioedema Paroxysmal nocturnal hemoglobinuria Leukocyte adhesion deficiency syndrome |
Sources: Adapted from Bonilla 2005, Merck Manual 2008.